The Vitals

Congress Expected To Weigh In On CVS-Aetna Merger

December 04, 2017
The House and Senate Judiciary committees are likely to hold hearings on health care giant CVS Health's plan to purchase Aetna for $69 billion, according to a health care analyst who predicts the mergers will face fewer hurdles than Aetna's earlier move to combine with Humana -- but still may not be a slam dunk. Ipsita Smolinski, managing director of Capital Street, said in a client memo that the deal, which could create a $240 billion company should it go...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.